Clients in the Media

November 12, 2025 | GATC Health
Rahul Gupta: Can Biotech Fix U.S. Healthcare Faster than Policy?
Inside Precision Medicine
November 12, 2025 | MeiraGTx
InnovationRx: Senate Punts On Health Insurance Subsidies To End Shutdown
Forbes (InnovationRx)
November 11, 2025 | Life Biosciences
This new drug may have cracked the cheat code for reversing aging
BBC Science
November 10, 2025 | MeiraGTx
Eli Lilly signs deal for MeiraGTx’s gene therapy for severe eye disease
Reuters
November 10, 2025 | MeiraGTx
In string of deals, Lilly nabs ultra rare eye disease gene therapy and RNAi partner
Endpoints
November 10, 2025 | MeiraGTx
Lilly’s pair of deals includes rights to MeiraGTx’s vision-restoring gene therapy: Deals Report
BioCentury
November 4, 2025 | Sparrow Pharmaceutials
BIO-Europe 2025: Sparrow Pharmaceuticals raised a $95M series B last month – it will be testing its cortisol depleting HSD1 inhibitor in treatment-resistant type 2 diabetes
BiotechTV
November 3, 2025 | Abivax
BIO-Europe 2025: Abivax CEO Marc de Garidel discusses physician and payor feedback after obefazimod’s phase 3 UC induction readouts, and next steps regarding maintenance and Crohn’s
BiotechTV
October 29, 2025 | GATC Health
AI in Drug Discovery & Development
Drug Discovery World
October 23, 2025 | Interius
First patient dosed with in vivo CAR-T therapy
STAT